BIT

BIOTRON FPO [BIT]
Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. The company's lead antiviral drug is BIT225 for the treatment of SARS-CoV-2, HIV-1, hepatitis C virus, hepatitis B virus (HBV), influenza, and dengue virus infections. The company was incorporated in 1999 and is based in Sydney, Australia.
Healthcare · ASX Small Cap
$0.0020 +0.0%

Updated 14 Jul 2026 · Signals refresh every scan

Get alerts when BIT triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Track BIT — Free

Active Signals

Bullish Signals

  • MACD momentum is losing steam
  • Stochastic is deep in oversold territory — bounce conditions forming
  • Sitting near support — this level has held before and could attract buyers again
  • Took a hit — down 20.0% over the last 5 days
  • Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
  • Low cash runway (3 quarters) - dilution risk
  • Near 52-week low (0% of range)
  • Micro-cap ($5-20M) - high risk
  • Sentiment is mixed — no strong consensus either way
  • The bigger volume days are the up days — volume-weighted momentum is positive (3.18%/day)
  • Pre-revenue company — Altman Z-Score not applicable
  • Penny stock risk ($0.002)
  • RBA hiking (-3pts)

Risk Signals

  • Below the 200-day average — the long-term trend is still working against it
  • Piotroski F-Score weak (3/9, low-confidence approx)
  • Not enough chatter to gauge sentiment — defaulting to neutral
  • Long-term momentum is negative — down 33% over the past year
Ask Scout AI about BIT
"What's driving BIT today?" "How does BIT compare to peers?" "Key risks for BIT?"
3 free messages/day · Unlimited with Pro

Recent Catalysts

NONE Application for quotation of securities - BIT
NONE Sedarex First Milestone Met
NONE Application for quotation of securities - BIT

Recent ASX Announcements

2026-07-13 Application for quotation of securities - BIT
2026-07-13 Sedarex First Milestone Met PRICE SENSITIVE
2026-06-17 Application for quotation of securities - BIT
2026-06-03 $525K R&D Rebate Received PRICE SENSITIVE
2026-05-29 Release From Voluntary Escrow

Key Metrics

$5.6M
Market Cap
2.3M
Avg Volume
0.8x
Vol Ratio
$0.00 — $0.01
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-122.6%
ROE
N/A
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSfailEPS Growth: 0%
AAnnual EarningsfailCAGR: 0%
NNew Highs / Catalystsneutral
SSupply & DemandneutralFloat: 63%
LLeader vs LaggardlaggardRS: -12
IInstitutional Sponsorshipinsufficient_dataInst: 0%
MMarket DirectionneutralNeutral

Sector: Healthcare

109 tickers in this sector

View all Healthcare signals →
Related Tickers
ECS -20.0%MEM -12.5%NTI +12.5%VBS +11.4%BDX +11.0%
Compare:BIT vs ECSBIT vs MEMBIT vs NTI
Scout Pro — Deeper Analysis for BIT
Try Pro free for 30 days
Share this analysis

Track BIT and 2,200+ ASX stocks

Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.

Open Dashboard — Free Free Screener
No credit card required